Syndax Pharmaceuticals won the first FDA approval last week in a new class of medicines called menin inhibitors. The treatment, Rejuforj, will be available as soon as this month for patients with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback